Funding round-up: AiVF, Axbio, Aidoc, LynxCare, 3Z

Iceland: 3Z, a drug discovery company, has closed a US$2m funding round led by seasoned investors in pharmaceuticals and medical technology. The Reykjavik based company will use funding to accelerate finalization of preclinical studies on 3Z´s lead therapeutic candidates in ADHD and insomnia. Using its unique zebrafish screening platform, 3Z has identified both novel and repurposed…

You must be a HMI Subscriber to view this content.

Subscribe Now »